Fetal Monitoring Global Market Report 2024

The primary product categories within fetal monitoring encompass ultrasound devices, electronic maternal or fetal monitors, uterine contraction monitors, fetal electrodes, fetal Doppler devices, telemetry devices, as well as accessories and consumables. Ultrasound devices, a form of medical imaging technology, generate images of the body's interior using high-frequency sound waves. These services employ both invasive and non-invasive methods and find applications in intrapartum fetal monitoring, antepartum fetal monitoring, and are utilized by end-users such as diagnostic laboratories, hospitals, clinics, and other healthcare facilities.

The fetal monitoring market research report provides fetal monitoring optical components market statistics, including fetal monitoring optical components industry global market size, regional shares, competitors with a fetal monitoring optical components market share, detailed fetal monitoring optical components market segments, market trends and opportunities, and any further data you may need to thrive in the fetal monitoring optical components industry. This fetal monitoring optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fetal monitoring market has grown strongly in recent years. It will grow from $3.63 billion in 2023 to $3.91 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%.
The growth observed in the historical period can be ascribed to factors such as a rise in maternal age, a high incidence of pregnancy complications, increased awareness and focus on prenatal care, governmental initiatives promoting maternal and child health, and an escalation in cesarean section rates.

The fetal monitoring market is expected to see strong growth in the next few years. It will grow to $5.31 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth in the forecast period can be linked to factors such as an increase in high-risk pregnancies, the prevalence of telehealth and remote monitoring trends, a focus on non-invasive monitoring solutions, collaborative efforts for research and development, and a patient-centric approach in maternity care. Noteworthy trends expected in the forecast period encompass wireless and wearable fetal monitoring devices, the integration of artificial intelligence (AI) in fetal monitoring, the provision of remote fetal monitoring services, emphasis on non-invasive monitoring technologies, and the development of portable and handheld fetal monitoring devices.

The fetal monitoring market is poised for growth, primarily propelled by the increasing prevalence of preterm births. Preterm births, occurring before the 37th week of pregnancy, are a significant concern due to their association with infant mortality and disability. Healthcare providers utilize fetal monitoring devices to continuously monitor parameters such as fetal heart rate and the mother's contractions, enabling timely interventions during delivery. The demand for fetal monitoring devices in hospitals and clinics is on the rise with the increasing occurrence of preterm deliveries. For example, as of November 2022, the World Health Organization reported an estimated 15 million premature births annually, accounting for over one in ten newborns. Consequently, the prevalence of preterm births acts as a driving force for the growth of the fetal monitoring market.

The anticipated increase in healthcare expenditure is set to contribute to the growth of the fetal monitoring market. Healthcare expenditure, encompassing both financial and non-financial resources allocated to healthcare-related goods and services, plays a crucial role in advancing technology, enhancing accessibility, supporting research and development initiatives, and overall improving the quality of maternal and fetal healthcare services. As of March 2022, the Centers for Medicare & Medicaid Services projected an average annual growth of 5.1% in national health spending between 2021 and 2030, reaching nearly $6.8 trillion. The expected annual growth rates of 7.2% for Medicare spending and 5.6% for Medicaid spending from 2021 to 2030 further underscore the impact of rising healthcare expenditure on driving the growth of the fetal monitoring market.

Major companies within the fetal monitoring market are at the forefront of developing cutting-edge technologies, such as AI-based fetal assessment platforms, aiming to cater to larger customer bases, boost sales, and increase revenue. An AI-based fetal assessment platform utilizes artificial intelligence (AI) algorithms and computational techniques to analyze and interpret data related to fetal well-being during pregnancy. For example, in August 2023, PeriGen Inc., a US-based provider of perinatal software solutions, introduced the LaborWatch platform. Distinguished as a groundbreaking platform, LaborWatch enhances intrapartum patient safety by promptly and transparently alerting hospital leadership to persistent deteriorating trends in laboring patients. Fueled by PeriWatch Vigilance, the exclusive AI-based maternal-fetal early warning system in the United States, LaborWatch autonomously identifies abnormal patient conditions and communicates notifications to the chain of command within a predefined timeframe. This streamlined process ensures that hospital leaders are promptly informed about critical situations, setting LaborWatch apart with its unique and effective approach.

Major companies in the fetal monitoring market are adopting a strategic partnership approach to offer a more comprehensive pregnancy care experience, spanning from the prenatal phase through labor and delivery. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. In March 2022, Royal Philips, a Netherlands-based provider of fetal monitoring solutions, formed a partnership with Nuvo Group Ltd., an Israel-based provider of medical devices. This collaboration involves Philips assisting Nuvo in conducting pilot programs for remote fetal monitoring to enhance accessibility and adherence to prescribed care, starting with a pilot program in rural Colorado. This partnership signifies Nuvo's commitment to delivering more comprehensive pregnancy care solutions to patients, providers, and payers.

In September 2021, GE HealthCare Technologies Inc., a US-based medical technology, pharmaceutical diagnostics, and digital solutions provider, acquired BK Medical Holding Company, Inc. for $1.45 billion. With this acquisition, GE Healthcare aims to expand its ultrasound business from diagnostics into surgical and therapeutic interventions using BK Medical's intraoperative imaging and surgical navigation solutions. BK Medical Holding Company, Inc. is a US-based company offering ultrasound imaging solutions for fetal monitoring.

Major companies operating in the fetal monitoring market report are Koninklijke Philips N.V., Fujifilm Holdings Corporation, Medtronic plc, Siemens Healthineers AG, GE Healthcare Company, Neoventa Medical AB, The Cooper Companies Inc., Spacelabs Healthcare Inc., Natus Medical Incorporated, EDAN Instruments Inc., Shenzhen Comen Medical Instruments Co. Ltd., Contec Medical Systems Co. Ltd., Bionet Co. Ltd., ArjoHuntleigh Inc., Analogic Corporation, Atom Medical Corporation, Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Cooper Surgical Inc., Covidien Ltd., Dixion Vertrieb medizinischer Geräte GmbH, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Corporation Limited, Huntleigh Healthcare Limited, Masimo Corporation, Mediana Co. Ltd., Mindray Medical International Limited, Nonin Medical Inc., OBMedical Company, PeriGen Inc., Sunray Medical Apparatus Co. Ltd., Toshiba Medical Systems Corporation.

North America was the largest region in the fetal monitoring market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global fetal monitoring market report forecast period. The regions covered in the fetal monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fetal monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fetal monitoring market includes revenues earned by entities by providing continuous electronic fetal monitoring, central fetal monitoring and intermittent auscultation. The market value includes the value of related goods sold by the service provider or included within the service offering. The fetal monitoring market also includes sales of tocodynamometer, fetal scalp electrode and intrauterine pressure catheter. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.